Related Experiment Video
Updated: Feb 3, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling
Nannan Guo1, Yingnan Zhao1, Wen Zhang1
1Department of Cardiothoracic Surgery, The First Affiliated Hospital of General Hospital of The Chinese People's Liberation Army, Beijing 100048, P.R. China.
Abstract:
MicroRNAs (miRNAs) may serve important roles in the regulation of human non-small cell lung cancer (NSCLC) cell growth and apoptosis. To the best of our knowledge, the present study was the first to explore the role of miRNA-133a/epidermal growth factor receptor (EGFR) in regulating NSCLC cell growth and apoptosis via the AKT/extracellular signal-regulated kinase (ERK) signaling pathway. It was determined that miRNA-133a expression was lower in NSCLC tissue than in the adjacent mucosae. Additionally, EGFR expression in the NSCLC tissue was higher compared with in the adjacent mucosae. Furthermore, the upregulation of miRNA-133a in NSCLC cells suppressed cell growth and induced apoptosis. Upregulating miRNA-133a also increased caspase-3 protein expression, while suppressing that of EGFR, phosphorylated (p)-AKT and p-ERK in NSCLC cells. Therefore, the results of the current study demonstrated that miRNA-133a downregulates EGFR expression in NSCLC via the AKT/ERK signaling pathway. These findings provide insights into the function of miRNA-133a in NSCLC, as well as into the molecular mechanisms underlying the miRNA-133a-mediated downregulation of the EGFR/AKT/ERK signaling pathway in NSCLC.
Insights
MicroRNA-133a (miRNA-133a) suppresses non-small cell lung cancer (NSCLC) growth by downregulating epidermal growth factor receptor (EGFR) and inhibiting the AKT/ERK pathway. This study reveals miRNA-133a as a potential therapeutic target for NSCLC.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are implicated in regulating non-small cell lung cancer (NSCLC) cell growth and apoptosis.
- The specific role of miRNA-133a in NSCLC, particularly its interaction with the epidermal growth factor receptor (EGFR) and the AKT/extracellular signal-regulated kinase (ERK) pathway, remains largely unexplored.
Purpose of the Study:
- To investigate the role of miRNA-133a in regulating NSCLC cell growth and apoptosis.
- To elucidate the molecular mechanism involving the epidermal growth factor receptor (EGFR) and the AKT/extracellular signal-regulated kinase (ERK) signaling pathway.
Main Methods:
- Comparative analysis of miRNA-133a and EGFR expression levels in NSCLC tissues versus adjacent mucosa.
- Experimental manipulation of miRNA-133a expression in NSCLC cells.
- Assessment of cell growth, apoptosis, and protein expression (caspase-3, EGFR, p-AKT, p-ERK).
Main Results:
- Lower miRNA-133a and higher EGFR expression were observed in NSCLC tissues.
- Upregulation of miRNA-133a suppressed NSCLC cell growth and induced apoptosis.
- Increased miRNA-133a led to elevated caspase-3 and reduced EGFR, p-AKT, and p-ERK protein levels.
Conclusions:
- MiRNA-133a acts as a tumor suppressor in NSCLC by downregulating EGFR expression.
- The mechanism involves the inhibition of the AKT/ERK signaling pathway.
- MiRNA-133a represents a potential therapeutic target for NSCLC treatment.
Related Concept Videos
MicroRNAs
What is Cell Signaling?
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
Cell-surface Signaling
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...

